Back to BARCLAYS PLC BARCLAYS PLC

COGTCOGT
Showing 8 of 18 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in COGENT BIOSCIENCES INC

Yes. Barclays holds 47,963 shares of COGT (Cogent Biosciences), worth $1.9M, as of its Q2 2026 13F filing. It increased the position by 16,702 shares (+53.4%) from Q1 2026. Barclays has held COGT since Q1 2022, across 18 quarterly 13F filings.

Current Value

$1.9M

Current Shares

47,963

Total Value Change

-$41,219

Total Shares Change

-127,721

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
47,963
+53.4%
$1.9M0.0%$38.70
36
2026-Q1
Decreased
31,261
-90.3%
$1.2M0.0%$37.24
0
2025-Q4
Decreased
321,606
-10.6%
$11.4M0.0%$37.12
0
2025-Q3
Increased
359,830
+12.3%
$5.2M0.0%$14.13
30
2025-Q2
Increased
320,565
+83.3%
$2.3M0.0%$7.10
40
2025-Q1
Decreased
174,918
-9.4%
$1M0.0%$6.48
0
2024-Q4
Increased
193,068
+9.9%
$1.5M0.0%$7.71
28
2024-Q3
Increased
175,684
+124.8%
$1.9M0.0%$10.90
42

Other major holders of COGT: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used